New Molecular Entities Approved In 2013
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Annual listing of novel drugs cleared by FDA’s Center for Drug Evaluation and Research.
You may also be interested in...
While Opening Dietary Ingredient Portfolio Wider, DuPont Opens Door On Online Supply Store
In its “robust, holistic hub” online, firms in the VMS product supply chain can determine their needs, “by product, solution or delivery formats,” and use a “comprehensive and unique portfolio” to “turn natural sources into shelf-ready products.”
Asia Deal Watch: Takeda, KSQ Take CRISPR Approach To T-Cell Oncology Therapy
Plus deals involving Astellas/Actinium, Sosei/PharmEnable, Aadi/EOC Pharma, BeiGene/Strand, Chi-Med/Inmagene, Alteogen/Intas, Sosei/AbbVie, Y-Biologics/3D Medicines.
J&J Has A Plan B If Gamechanger Single Dose Vaccine Disappoints
If J&J’s gamble on a single dose pays off, it could rapidly advance the fight against SARS-CoV2 – but a second study will provide a safety net.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: